Log in

AMERISAFE Stock Forecast, Price & News

-0.63 (-1.11 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $56.00
50-Day Range
MA: $58.35
52-Week Range
Now: $56.00
Volume29,633 shs
Average Volume103,086 shs
Market Capitalization$1.08 billion
P/E Ratio11.74
Dividend Yield1.91%
AMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. Its workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. The company provides workers' compensation insurance for small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, agriculture, maritime, and oil and gas. The company was incorporated in 1985 and is headquartered in DeRidder, Louisiana.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.17 out of 5 stars

Industry, Sector and Symbol

Industry Fire, marine, & casualty insurance
Sub-IndustryProperty & Casualty Insurance
Current SymbolNASDAQ:AMSF



Sales & Book Value

Annual Sales$370.37 million
Cash Flow$4.98 per share
Book Value$24.93 per share


Net Income$92.69 million


Market Cap$1.08 billion
Next Earnings Date2/17/2021 (Estimated)
-0.63 (-1.11 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMSF News and Ratings via Email

Sign-up to receive the latest news and ratings for AMSF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AMERISAFE (NASDAQ:AMSF) Frequently Asked Questions

How has AMERISAFE's stock price been impacted by Coronavirus (COVID-19)?

AMERISAFE's stock was trading at $60.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMSF stock has decreased by 8.2% and is now trading at $56.00.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of AMERISAFE?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for AMERISAFE

What stocks does MarketBeat like better than AMERISAFE?

Wall Street analysts have given AMERISAFE a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AMERISAFE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is AMERISAFE's next earnings date?

AMERISAFE is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for AMERISAFE

How were AMERISAFE's earnings last quarter?

AMERISAFE, Inc. (NASDAQ:AMSF) posted its quarterly earnings results on Monday, November, 2nd. The insurance provider reported $1.16 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.44. AMERISAFE had a return on equity of 20.22% and a net margin of 26.84%.
View AMERISAFE's earnings history

How often does AMERISAFE pay dividends? What is the dividend yield for AMERISAFE?

AMERISAFE declared a None dividend on Wednesday, October 28th. Shareholders of record on Wednesday, November 11th will be given a dividend of $3.50 per share on Wednesday, November 18th. The ex-dividend date is Monday, November 9th.
View AMERISAFE's dividend history

What price target have analysts set for AMSF?

3 brokerages have issued 1 year price targets for AMERISAFE's shares. Their forecasts range from $72.00 to $80.00. On average, they expect AMERISAFE's share price to reach $76.00 in the next year. This suggests a possible upside of 35.7% from the stock's current price.
View analysts' price targets for AMERISAFE

Who are some of AMERISAFE's key competitors?

What other stocks do shareholders of AMERISAFE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

Who are AMERISAFE's key executives?

AMERISAFE's management team includes the following people:
  • Ms. Gerry Janelle Frost, Pres, CEO & Director (Age 49, Pay $1.1M)
  • Mr. Neal Andrew Fuller, Exec. VP & CFO (Age 58, Pay $619.9k)
  • Ms. Kathryn Housh Shirley, Exec. VP, Chief Admin. Officer & Sec. (Age 54, Pay $412.98k)
  • Mr. Vincent John Gagliano, Exec. VP & Chief Risk Officer (Age 47, Pay $447.27k)
  • Mr. Andrew Brook McCray, Exec. VP & Chief Underwriting Officer (Age 58, Pay $336.1k)
  • Mr. David Ronald Morton, Sr. VP of Sales & Marketing (Age 49)
  • Mr. Henry Oscar Lestage IV, Sr. VP of Claims Operations (Age 59)
  • Mr. Leon J. Lagneaux IV, Sr. VP of Recruitment & Devel. (Age 68)
  • Ms. Kelly Renee Goins, Sr. VP of Underwriting Operations (Age 54)
  • Ms. Barbra E. McCrary, Sr. VP of Policyholder Services (Age 45)

What is AMERISAFE's stock symbol?

AMERISAFE trades on the NASDAQ under the ticker symbol "AMSF."

Who are AMERISAFE's major shareholders?

AMERISAFE's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.79%), Neuberger Berman Group LLC (8.41%), Victory Capital Management Inc. (5.23%), State Street Corp (3.20%), GW&K Investment Management LLC (2.36%) and Standard Life Aberdeen plc (2.16%). Company insiders that own AMERISAFE stock include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, Randy Roach and Vincent J Gagliano.
View institutional ownership trends for AMERISAFE

Which institutional investors are selling AMERISAFE stock?

AMSF stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Neuberger Berman Group LLC, Assenagon Asset Management S.A., JPMorgan Chase & Co., Morgan Stanley, State Street Corp, First Trust Advisors LP, and SG Americas Securities LLC. Company insiders that have sold AMERISAFE company stock in the last year include G Janelle Frost, Kathryn Housh Shirley, Neal Andrew Fuller, and Vincent J Gagliano.
View insider buying and selling activity for AMERISAFE

Which institutional investors are buying AMERISAFE stock?

AMSF stock was purchased by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, BlackRock Inc., Victory Capital Management Inc., TD Asset Management Inc., Great West Life Assurance Co. Can, AQR Capital Management LLC, M&G Investment Management Ltd., and Mackay Shields LLC.
View insider buying and selling activity for AMERISAFE

How do I buy shares of AMERISAFE?

Shares of AMSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AMERISAFE's stock price today?

One share of AMSF stock can currently be purchased for approximately $56.00.

How big of a company is AMERISAFE?

AMERISAFE has a market capitalization of $1.08 billion and generates $370.37 million in revenue each year. The insurance provider earns $92.69 million in net income (profit) each year or $4.60 on an earnings per share basis. AMERISAFE employs 431 workers across the globe.

What is AMERISAFE's official website?

The official website for AMERISAFE is www.amerisafe.com.

How can I contact AMERISAFE?

AMERISAFE's mailing address is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. The insurance provider can be reached via phone at 337-463-9052 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.